Total Share Capital Notification
19th November 2020 - 11:39 amThe following replaces the ‘Total Share Capital Notification’ announcement released on 30 September 2020 at 7.01am (BST) under RNS No 5041A.
In Section 2 below the reference to “Share Options in whole or part” should have stated 25,640,254 not 15,703,942.
| 1. Information to be provided for on the basis of Article 15, §1, al. 1
| ||
| Total of share capital (nominal value) | : | £ 24,628,580 |
| Total number of shares with existing voting rights (= denominator) – one vote per share | : | 246,285,805 |
| 2. Additional information to be provided on the basis of Article 15, §1, al. 2
In respect to the announcement on 11 June 2020: “Investment from two specialist US healthcare investors” | ||
| Convertible Securities (in whole or in part) into ordinary shares currently outstanding. The total conversion would result in an equal number of voting rights | : | 10,734,166 |
| Share options (in whole or in part) The exercise of the options would result in the creation of an equal number of ordinary shares and voting rights.
| : | 25,640,254 |
| In respect to the announcements on 30 March 2020: “Subscription to raise £1.5m” and 2 September 2020 “Placing to raise £6.5m” | ||
| Warrants over ordinary shares (in whole or in part) The exercise of the warrants would result in the creation of an equal number of ordinary shares and voting rights | : | 3,343,045 |
| Other outstanding rights to subscribe ordinary shares as detailed in the Annual Report 2019 (Report and consolidated financial Statements for the year ended 31 December 2019) | ||
| Share options (in whole or in part) The exercise of the options would result in the creation of an equal number of ordinary shares and voting rights | : | 16,368,850 |
For the full amended text click here